BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23224713)

  • 1. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model.
    Vellimana AK; Recinos VR; Hwang L; Fowers KD; Li KW; Zhang Y; Okonma S; Eberhart CG; Brem H; Tyler BM
    J Neurooncol; 2013 Feb; 111(3):229-36. PubMed ID: 23224713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
    Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
    Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
    Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats.
    Tyler B; Fowers KD; Li KW; Recinos VR; Caplan JM; Hdeib A; Grossman R; Basaldella L; Bekelis K; Pradilla G; Legnani F; Brem H
    J Neurosurg; 2010 Aug; 113(2):210-7. PubMed ID: 20001591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.
    Tyler BM; Hdeib A; Caplan J; Legnani FG; Fowers KD; Brem H; Jallo G; Pradilla G
    J Neurosurg Spine; 2012 Jan; 16(1):93-101. PubMed ID: 22208429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
    Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
    J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis.
    Gok B; McGirt MJ; Sciubba DM; Garces-Ambrossi G; Nelson C; Noggle J; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL
    Neurosurgery; 2009 Jul; 65(1):193-9; discussion 199-200. PubMed ID: 19574842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models.
    Grossman R; Brastianos H; Blakeley JO; Mangraviti A; Lal B; Zadnik P; Hwang L; Wicks RT; Goodwin RC; Brem H; Tyler B
    J Neurooncol; 2014 Jan; 116(1):59-65. PubMed ID: 24185441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin.
    Grossman R; Tyler B; Hwang L; Zadnik P; Lal B; Javaherian K; Brem H
    J Neurosurg; 2011 Dec; 115(6):1139-46. PubMed ID: 21923243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
    Wicks RT; Azadi J; Mangraviti A; Zhang I; Hwang L; Joshi A; Bow H; Hutt-Cabezas M; Martin KL; Rudek MA; Zhao M; Brem H; Tyler BM
    Neuro Oncol; 2015 Jan; 17(1):70-80. PubMed ID: 25053853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
    Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA
    J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model.
    Serra R; Mangraviti A; Gorelick NL; Shapira-Furman T; Alomari S; Cecia A; Darjee N; Brem H; Rottenberg Y; Domb AJ; Tyler B
    Eur J Pharm Biopharm; 2022 Jan; 170():179-186. PubMed ID: 34968646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.
    Masi BC; Tyler BM; Bow H; Wicks RT; Xue Y; Brem H; Langer R; Cima MJ
    Biomaterials; 2012 Aug; 33(23):5768-75. PubMed ID: 22591609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epirubicin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
    Recinos VR; Bekelis K; Ziegler SG; Vick D; Hertig S; Tyler BM; Li KW; Kosztowski T; Legnani FG; Brem H; Olivi A
    J Neurooncol; 2010 Mar; 97(1):1-10. PubMed ID: 19693439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of temozolomide delivered by prolonged intracerebral microinfusion against the rat brainstem GBM allograft model.
    Yoshimura J; Siu IM; Thomale UW; Jallo GI
    Childs Nerv Syst; 2012 May; 28(5):707-13. PubMed ID: 22391876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of oncogel delays paresis in rat metastatic spinal tumor model.
    Bagley CA; Bookland MJ; Pindrik JA; Ozmen T; Gokaslan ZL; Witham TF
    J Neurosurg Spine; 2007 Aug; 7(2):194-8. PubMed ID: 17688059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.
    Banissi C; Ghiringhelli F; Chen L; Carpentier AF
    Cancer Immunol Immunother; 2009 Oct; 58(10):1627-34. PubMed ID: 19221744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
    Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
    J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.